DIAGNOSTEK RxCHOICE RETAIL/MAIL INTEGRATED PROGRAM WILL GENERATE $15-$20 MIL. IN MARCH 31 QUARTER; CREDIT CARD-LINKED SERVICE OFFERED TO 17 MIL. NRECA MEMBERS
Executive Summary
Diagnostek's RxChoice retail/mail integrated service will handle $15-$20 mil. of prescription sales during the quarter ending March 31, the company projects. "Based upon...our trends in those retail script processing we could run somewhere between $15 and $20 mil.," Diagnostek Exec VP-CFO William Barron told a teleconference with securities analysts on March 7.